Results 221 to 230 of about 139,183 (310)

Anti-RNApol3-Associated myocarditis: an emerging disease linking autoimmunity and infection. [PDF]

Ann Intensive Care
Quentric P, Charuel JL, Moyon Q, Hékimian G, Dorgham K, Lifermann F, Kerneis M, Mathian A, Aacha K, Melki I, Chommeloux J, Petit M, Gautier M, Bay P, Rouvier P, Charpentier E, da Mata-Jardin O, Lefevre L, Parizot C, Saura O, Levy D, Ortuno S, Schmidt M, Luyt CE, Gorochov G, Amoura Z, Combes A, Pineton de Chambrun M.   +27 more
europepmc   +1 more source

Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysis. [PDF]

J Scleroderma Relat Disord
Boleto G, Campochiaro C, Distler O, Balanescu A, Launay D, Bergmann C, Airò P, Oksel F, Gheorghiu AM, Anic B, Mouthon L, Yavuz S, Tanaseanu CM, Matucci-Cerinic M, Allanore Y.   +14 more
europepmc   +1 more source

Management of Cutaneous Lesions in Brunsting–Perry Pemphigoid (Bpp): A Single‐Center Retrospective Cohort Study

JEADV Clinical Practice, EarlyView.
Shirley P. Parraga, Matthew L. Hrin, Sarah N. Rimmer, Joseph L. Jorizzo   +3 more
wiley   +1 more source

Immune cell alterations in a pristane‐induced lupus model in C57BL/6J mice

Rheumatology &Autoimmunity, EarlyView.
A pristane‐induced systemic lupus erythematosus model was established in C57BL/6J mice. Mice were randomly assigned to a pristane group (0.5 mL pristane intraperitoneally) or a control group (0.5 mL saline intraperitoneally). Six months later, levels of antinuclear antibodies, serum inflammatory cytokines, urinary protein, renal injury, and immune cell
Yali Zhou, Binbin Yang, Haojun Long, Qinghuan Zhu, Yongzhuo Wu, Yingying Liu, Limei Yuan, Wenting Cao, Xinwei Huang, Danqi Deng   +9 more
wiley   +1 more source

Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer. [PDF]

Front Immunol
Ye Y, Huang Y, Pan J.
europepmc   +1 more source

Bullous Pemphigoid Presenting as Immunoglobulin M Pemphigoid

JEADV Clinical Practice, EarlyView.
D. Didona, R. Maglie, A. M. Sequeira Santos, V. Schwarz, M. Hertl, F. Solimani   +5 more
wiley   +1 more source

Serum and tear autoantibodies from NOD and NOR mice as potential diagnostic indicators of local and systemic inflammation in Sjögren's disease. [PDF]

Front Immunol
Singh Kakan S, Abdelhamid S, Ju Y, MacKay JA, Edman MC, Raman I, Zhu C, Raj P, Hamm-Alvarez SF.   +8 more
europepmc   +1 more source

Hetrombopag: A promising thrombopoietin receptor agonist for the treatment of primary and secondary immune thrombocytopenia

Rheumatology &Autoimmunity, EarlyView.
This review seeks to provide a thorough synthesis of the existing literature on the role of thrombopoietin receptor agonists in the treatment of primary and secondary immune thrombocytopenia, with particular emphasis on the compound Hetrombopag. Abstract Immune thrombocytopenia (ITP) is a rare autoimmune disorder characterized by a platelet count below
Jiaqi Hu, Zhida Fu, Xia Xu, Zhengyi Jin, Xinyu Qian, Weiyu Tao, Taiyan Ma, Dongbao Zhao, Jie Gao   +8 more
wiley   +1 more source

Autoantibodies in childhood connective tissue diseases and in normal children.

, 1975
K M Goel, Robert A. Shanks, K Whaley, Mary Jane Mason, R N MacSween   +4 more
openalex   +1 more source

Treatment strategy for systemic lupus erythematosus using belimumab as indicated by multi‐omics analysis

Rheumatology &Autoimmunity, EarlyView.
Recent multi‐omics studies have demonstrated that belimumab specifically targets naïve B cells and a subset of memory B cells. This observation is consistent with belimumab's established efficacy and safety profile. Abstract Belimumab is an antibody targeting the cytokine B‐cell activating factor (BAFF), which is crucial for B cell differentiation, and
Keishi Fujio, Toshiyuki Ushijima, Tatsuki Abe, Tomohisa Okamura, Sang‐Cheol Bae, Yumi Tsuchida   +5 more
wiley   +1 more source